The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption

  title={The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption},
  author={A. Traish},
  journal={Current Sexual Health Reports},
  • A. Traish
  • Published 2018
  • Medicine
  • Current Sexual Health Reports
Purpose of ReviewPost-finasteride syndrome (PFS) is a disorder characterized by a set of clinical symptoms experienced during use or after drug discontinuation. This cluster of symptoms encompasses overall sexual dysfunction (SD), erectile dysfunction (ED), loss of libido, depression, suicidal ideation, anxiety, panic attacks, insomnia, and cognitive dysfunction. To date, there is lack of comprehensive understanding of the biochemical and pathophysiological mechanisms responsible for the… Expand
Post-finasteride syndrome: a surmountable challenge for clinicians.
The author believes that finasteride and dutasteride induce a constellation of persistent sexual, neurological and physical adverse side effects, in a subset of men, which constitute the basis for Post-finasteride syndrome in individuals predisposed to epigenetic susceptibility. Expand
Post-Finasteride Syndrome - When will we Get the Courage to Fight the Dictating Pharma Industry - Despite Awareness of "Sexual, Neurological and Metabolic Side Effects in Young Men for Over a Decade"
This comprehensive review has been done with an effort for the medical community who took hippocratic oath to serve the humanity why they cannot get up and protest against the side effects that in a subgroup of men might get irreversible side effects rather than label the poor men as psychotic or delusional. Expand
Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm
  • A. Traish
  • Medicine
  • The world journal of men's health
  • 2020
It is suggested that long-term use of finasteride and dutasteride may be associated with health risks including NAFLD, IR, T2DM, dry eye disease and potential kidney disease and this treatment may result in development of non-alcoholic fatty liver diseases (NAFLD), insulin resistance (IR), type 2 diabetes (T2DM),dry eye disease, potential kidney dysfunction, and metabolic dysfunctions. Expand
Benign Prostatic Hyperplasia and Chronic Prostatitis Thermobalancing Therapy Can Prevent Sexual Dysfunction and Depression Linked to Medications: Importance During a Pandemic
The wider use of DATD in healthcare systems will decrease male visits to hospitals, diminishing the risks of contracting a viral infection and transmitting it to others during a coronavirus outbreak or another pandemic. Expand
Benign Prostatic Hyperplasia and Kidney Stone Disease Thermobalancing Therapy with Dr Allen’s Device: Key to Successful Ageing Without Medications, Surgery, and Risky Exposure to Coronavirus Infection
Background: The choice of treatment for benign prostatic hyperplasia (BPH) and kidney stone disease (KSD) impacts the attainment of successful ageing and the level of patient care required in theExpand
Understanding how Age-Related Decline in Testosterone Affects Male Sexual Behavior: Neurosteroids as the Missing Piece
Understanding of how age-related decreases in circulating androgens influence neural circuits that mediate sexual behavior and reward is summarized, and recent findings in the understanding of androgen receptors, neuroandrogens, and sexual function in healthy aged men are highlighted. Expand
Paternal Finasteride Treatment Can Influence the Testicular Transcriptome Profile of Male Offspring-Preliminary Study.
(1) Background: Hormone-dependent events that occur throughout spermatogenesis during postnatal testis maturation are significant for adult male fertility. Any disturbances in the T/DHT ratio in maleExpand


Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?
The present review will report the state of art of these two different pathologies and discuss, on the basis of the role exerted by three different neuromodulators such as dopamine, serotonin and neuroactive steroids, whether the persistent sexual dysfunction observed could be determined by common mechanisms. Expand
Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients
Finasteride did not only affect the levels of 5alpha-reduced metabolites of progesterone and testosterone, but also the further metabolites and precursors suggesting that this drug has broad consequence on neuroactive steroid levels of PFS patients. Expand
Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
The aim of this study is to review the existing medical literature for evidence-based research of permanent sexual dysfunction and mood changes during treatment with 5-alpha-reductase inhibitors including finasteride and dutasteride. Expand
Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma
Observations performed in a subset of patients treated for male pattern hair loss indicate that persistent sexual side effects as well as anxious/depressive symptomatology have been reported evenExpand
Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.
INTRODUCTION 5α-reductase inhibitors (5α-RIs), finasteride and dutasteride, have been approved for treatment of lower urinary tract symptoms, due to benign prostatic hyperplasia, with marked clinicalExpand
Persistent Sexual, Emotional, and Cognitive Impairment Post-Finasteride
Finasteride is a synthetic 5-α reductase inhibitor, which prevents the conversion of testosterone to dihydrotestosterone and has been used for more than 20 years in the treatment of male pattern hairExpand
Depression Circumstantially Related to the Administration of Finasteride for Androgenetic Alopecia
Depression, which significatively impaired sociofamilial relations, sleep and eating behaviour, was associated to marked anxiety in some cases, developed after 9–19 weeks of treatment with finasteride, and promptly resolved after suspension of the drug. Expand
Emotional Consequences of Finasteride: Fool’s Gold
Results provide evidence on the need to screen for psychiatric history and counseling patients about the potential psychological consequences of finasteride, and prescribing clinicians should carefully weigh the risk/benefit ratio with these patients. Expand
Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens
A number of novel potential chemical targets of FIN are pointed to, which may help elucidate the underpinnings of FIN's behavioral effects and therapeutic potential for neuropsychiatric disorders. Expand
Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
To assess whether longer duration of 5α-RI exposure increases risk of PED, independent of age and other known risk factors, a single-group study design and classification tree analysis (CTA) was used to model PED. Expand